Taro-Budesonide 0.25 mg

TARO-BUDESONIDE 0.25 MG is a corticosteroid suspension used for inhalation. It helps reduce inflammation in the lungs, often for conditions like asthma. This medication is manufactured by Taro Pharmaceuticals Inc. in Canada.

TARO-BUDESONIDE 0.25 MG is primarily used for managing asthma and other respiratory conditions that involve inflammation. It works by reducing swelling and irritation in the airways, making it easier to breathe. This medication is often prescribed for long-term control rather than immediate relief.

Common effects of TARO-BUDESONIDE 0.25 MG may include throat irritation, hoarseness, or a fungal infection in the mouth. Some users might experience coughing or a bad taste in the mouth. These effects are generally mild and temporary.

It is important to use TARO-BUDESONIDE 0.25 MG as directed by a healthcare provider. Rinse your mouth after each use to reduce the risk of oral thrush. Avoid sudden discontinuation without medical advice, as this can worsen symptoms.

TARO-BUDESONIDE 0.25 MG may interact with other medications, including certain antifungal drugs and HIV protease inhibitors. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.